Article
Characterization of glucagon-like peptide-1 receptor-binding determinants.
Journal of molecular endocrinology - 1 Dec 2000
Xiao Q, Jeng W, Wheeler M B
Abstract excerpt
Glucagon-like peptide 1 (GLP-1) is a potent insulinotropic hormone currently under study as a therapeutic agent for type 2 diabetes. Since an understanding of the molecular mechanisms leading to high-affinity receptor (R) binding and activation may facilitate the development of more potent GLP-1R agonists, we have localized specific regions of GLP-1R required for binding. The purified N-terminal fragment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
